Clinical Trials
13 trialsNCT02954874 2026-05-15
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT05333874 2026-02-09
CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage
Rutgers, The State University of New Jersey
Phase EARLY_PHASE1 Active not recruiting
NCT07262138 2025-12-03
ACTIVE
University of Pittsburgh
Recruiting
NCT03418961 2025-10-08
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
SWOG Cancer Research Network
Phase 3 Recruiting
NCT04625023 2025-05-01
METAMECH
IFOM ETS - The AIRC Institute of Molecular Oncology
Recruiting
NCT00080756 2024-08-28
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease
City of Hope Medical Center
Phase 2 Active not recruiting
NCT04016935 2022-05-17
EndoPredict® Extended Endocrine Trial (EXET)
Myriad Genetic Laboratories, Inc.
Terminated
NCT03161834 2021-05-21
Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer
UNC Lineberger Comprehensive Cancer Center
Withdrawn
NCT01867229 2019-04-10
chemo-ameno
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Completed
NCT00445952 2018-02-01
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
European Organisation for Research and Treatment of Cancer - EORTC
Completed
NCT00632047 2013-08-26
Early Detection of Breast Cancer and Cervical Cancer in Women in India
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01666171 2013-07-10
Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32
National Cancer Institute (NCI)
Unknown
NCT00433602 2013-06-12
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Completed